New monthly shot could help shed pounds in obesity trial
NCT ID NCT06973720
First seen Jan 24, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests a new drug called MET097 to help people with obesity or overweight lose weight. Participants receive weekly injections for 12 weeks, then switch to monthly doses for up to 64 weeks. The goal is to see if the drug is safe and effective compared to a placebo. About 268 adults without type 2 diabetes are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CenExel iResearch, LLC
Decatur, Georgia, 30030, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
ForCare Clinical Research
Tampa, Florida, 33613, United States
-
Hassman Research Institute
Marlton, New Jersey, 08053, United States
-
Research Centers of America
Hollywood, Florida, 33024, United States
Conditions
Explore the condition pages connected to this study.